Inhibition and gene deletions experiments revealed that the activation of NFκB is a central mediator of chronic inflammatory diseases, including inflammatory bowel diseases, rheumatoid arthritis, and asthma. This evidence concerns the gene NFKB1 and rheumatoid arthritis.